Nick Gagnon

VP, Head of Late Stage Partnering at IPSEN

Speaker

Nick joined Ipsen in 2019 and brings more than 15 years of global business development experience spanning North America, Europe, and Asia. During his tenure at Ipsen, he has played a pivotal role in delivering over 25 programs into the company’s pipeline and commercial portfolio through external partnerships and M&As.

As Vice President, Head of Late Stage Partnering, Nick leads the execution of post–proof‑of‑concept transactions across Ipsen’s three therapeutic areas—oncology, rare disease, and neuroscience. His work focuses on securing innovative, high‑value partnerships that strengthen Ipsen’s late‑stage pipeline and drive long‑term growth.

Nick holds both a B.Sc. and M.Sc. in Microbiology and Immunology from McGill University and an MBA from the MIT Sloan School of Management.